Differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide-induced cytokine and chemokine synthesis

被引:63
作者
Aronoff, David M.
Carstens, Jennifer K.
Chen, Gwo-Hsiao
Toews, Galen B.
Peters-Golden, Marc
机构
[1] Univ Michigan, Dept Internal Med, Div Infect Dis, Hlth Syst, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1089/jir.2006.26.827
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Cyclic adenosine monophosphate (cAMP) is an intracellular signaling molecule responsible for directing cellular responses to extracellular signals. Once believed to signal exclusively through its ability to bind protein kinase A (PKA), recent research has revealed alternative cAMP-binding targets involved in PKA-independent processes. In this study we addressed the hypothesis that the guanine nucleotide exchange protein directly activated by cAMP (Epac-1) and PKA differentially regulate inflammatory mediator production in distinct phagocytic cell types. To accomplish this, we compared the release of cAMP-regulated polypeptide inflammatory mediators in both macrophages (obtained from the lung and peritoneum) and bone marrow-derived dendritic cells (DCs) stimulated with bacterial endotoxin. Using the highly selective Epac-1 and PKA activating cAMP analogs 8-pCPT-2'-O-Me-cAMP and 6-Bnz-cAMP, respectively, we found that macrophages differ from DCs in the involvement of these distinct cAMP pathways in modulating inflammatory mediator release in response to endotoxin. Whereas the regulation of cytokine and chemokine production in macrophages by cAMP was solely dependent on PKA, we found that both Epac-1 and PKA activation could regulate mediator production in DCs. This finding may be important in the pharmacologic regulation of immune responses through manipulation of cAMP signaling cascades and contributes to our understanding of the differences between these cell types.
引用
收藏
页码:827 / 833
页数:7
相关论文
共 29 条
[1]
Cutting edge: Macrophage inhibition by cyclic AMP (cAMP): Differential roles of protein kinase A and exchange protein directly activated by cAMP-1 [J].
Aronoff, DM ;
Canetti, C ;
Serezani, CH ;
Luo, M ;
Peters-Golden, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :595-599
[2]
Epac: a new cAMP target and new avenues in cAMP research [J].
Bos, JL .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (09) :733-738
[3]
Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1β production [J].
Caggiano, AO ;
Kraig, RP .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :565-575
[4]
Novel receptor partners and function of receptor activity-modifying proteins [J].
Christopoulos, A ;
Christopoulos, G ;
Morfis, M ;
Udawela, M ;
Laburthe, M ;
Couvineau, A ;
Kuwasako, K ;
Tilakaratne, N ;
Sexton, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3293-3297
[5]
The cAMP-Epac-Rap1 pathway regulates cell spreading and cell adhesion to laminin-5 through the α3β1 integrin but not the α6β4 integrin [J].
Enserink, JM ;
Price, LS ;
Methi, T ;
Mahic, M ;
Sonnenberg, A ;
Bos, JL ;
Taskén, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :44889-44896
[6]
A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK [J].
Enserink, JM ;
Christensen, AE ;
de Rooij, J ;
van Triest, M ;
Schwede, F ;
Genieser, HG ;
Doskeland, SO ;
Blank, JL ;
Bos, JL .
NATURE CELL BIOLOGY, 2002, 4 (11) :901-906
[7]
INHIBITION BY PROSTAGLANDINS OF LEUKOTRIENE-B4 RELEASE FROM ACTIVATED NEUTROPHILS [J].
HAM, EA ;
SODERMAN, DD ;
ZANETTI, ME ;
DOUGHERTY, HW ;
MCCAULEY, E ;
KUEHL, FA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4349-4353
[8]
Prostaglandin E2 downregulates interleukin-12 production through EP4 receptors in human monocytes stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans and interferon-γ [J].
Iwasaki, K ;
Noguchi, K ;
Endo, H ;
Kondo, H ;
Ishikawa, I .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2003, 18 (03) :150-155
[9]
A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2 [J].
Jing, H ;
Yen, JH ;
Ganea, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) :55176-55186
[10]
Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells [J].
Jing, H ;
Vassiliou, E ;
Ganea, D .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (05) :868-879